Inhibition of immunoproteasome LMP2 promotes angiogenesis and enhances HIF-1α accumulation in a rat model of cerebral ischemia [10], supporting the conclusion that the immunoproteasome possesses proteolytic activity involved in protein degradation. The gene discussed is HIF1A; the disease is Cerebral ischemia.